These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 8843466)
1. Fumonisins, mycotoxins of increasing importance: their nature and their effects. Dutton MF Pharmacol Ther; 1996; 70(2):137-61. PubMed ID: 8843466 [TBL] [Abstract][Full Text] [Related]
2. Disruption of sphingolipid metabolism and stimulation of DNA synthesis by fumonisin B1. A molecular mechanism for carcinogenesis associated with Fusarium moniliforme. Schroeder JJ; Crane HM; Xia J; Liotta DC; Merrill AH J Biol Chem; 1994 Feb; 269(5):3475-81. PubMed ID: 8106389 [TBL] [Abstract][Full Text] [Related]
3. Discovery and occurrence of the fumonisins: a historical perspective. Marasas WF Environ Health Perspect; 2001 May; 109 Suppl 2(Suppl 2):239-43. PubMed ID: 11359691 [TBL] [Abstract][Full Text] [Related]
4. Subchronic toxic effects of Fusarium moniliforme and fumonisin B1 in rats and mice. Voss KA; Riley RT; Bacon CW; Chamberlain WJ; Norred WP Nat Toxins; 1996; 4(1):16-23. PubMed ID: 8680749 [TBL] [Abstract][Full Text] [Related]
5. An overview of rodent toxicities: liver and kidney effects of fumonisins and Fusarium moniliforme. Voss KA; Riley RT; Norred WP; Bacon CW; Meredith FI; Howard PC; Plattner RD; Collins TF; Hansen DK; Porter JK Environ Health Perspect; 2001 May; 109 Suppl 2(Suppl 2):259-66. PubMed ID: 11359694 [TBL] [Abstract][Full Text] [Related]
6. Fumonisins: their implications for human and animal health. Marasas WF Nat Toxins; 1995; 3(4):193-8; discussion 221. PubMed ID: 7582616 [TBL] [Abstract][Full Text] [Related]
7. Fumonisins--mycotoxins produced by Fusarium moniliforme. Norred WP J Toxicol Environ Health; 1993 Mar; 38(3):309-28. PubMed ID: 8450559 [TBL] [Abstract][Full Text] [Related]
8. In vivo effects of fumonisin B1-producing and fumonisin B1-nonproducing Fusarium moniliforme isolates are similar: fumonisins B2 and B3 cause hepato- and nephrotoxicity in rats. Voss KA; Plattner RD; Riley RT; Meredith FI; Norred WP Mycopathologia; 1998; 141(1):45-58. PubMed ID: 9725030 [TBL] [Abstract][Full Text] [Related]
9. Fumonisin contamination of food: progress in development of biomarkers to better assess human health risks. Turner PC; Nikiema P; Wild CP Mutat Res; 1999 Jul; 443(1-2):81-93. PubMed ID: 10415433 [TBL] [Abstract][Full Text] [Related]
10. Effects of fusarium moniliforme isolates on tissue and serum sphingolipid concentrations in horses. Goel S; Schumacher J; Lenz SD; Kemppainen BW Vet Hum Toxicol; 1996 Aug; 38(4):265-70. PubMed ID: 8829343 [TBL] [Abstract][Full Text] [Related]
12. Carcinogenicity and mechanism of action of fumonisin B1: a mycotoxin produced by Fusarium moniliforme (= F. verticillioides). Voss KA; Howard PC; Riley RT; Sharma RP; Bucci TJ; Lorentzen RJ Cancer Detect Prev; 2002; 26(1):1-9. PubMed ID: 12088196 [TBL] [Abstract][Full Text] [Related]
13. Disruption of sphingolipid metabolism in non-human primates consuming diets of fumonisin-containing Fusarium moniliforme culture material. Shephard GS; van der Westhuizen L; Thiel PG; Gelderblom WC; Marasas WF; van Schalkwyk DJ Toxicon; 1996 May; 34(5):527-34. PubMed ID: 8783447 [TBL] [Abstract][Full Text] [Related]
14. Characterization of cell-cycle arrest by fumonisin B1 in CV-1 cells. Ciacci-Zanella JR; Merrill AH; Wang E; Jones C Food Chem Toxicol; 1998; 36(9-10):791-804. PubMed ID: 9737426 [TBL] [Abstract][Full Text] [Related]
15. Induction of apoptosis by fumonisin B1 in HT29 cells is mediated by the accumulation of endogenous free sphingoid bases. Schmelz EM; Dombrink-Kurtzman MA; Roberts PC; Kozutsumi Y; Kawasaki T; Merrill AH Toxicol Appl Pharmacol; 1998 Feb; 148(2):252-60. PubMed ID: 9473533 [TBL] [Abstract][Full Text] [Related]
16. Fumonisin toxicity and metabolism studies at the USDA. Fumonisin toxicity and metabolism. Norred WP; Voss KA; Riley RT; Plattner RD Adv Exp Med Biol; 1996; 392():225-36. PubMed ID: 8850620 [TBL] [Abstract][Full Text] [Related]
17. Increases in serum sphingosine and sphinganine and decreases in complex sphingolipids in ponies given feed containing fumonisins, mycotoxins produced by Fusarium moniliforme. Wang E; Ross PF; Wilson TM; Riley RT; Merrill AH J Nutr; 1992 Aug; 122(8):1706-16. PubMed ID: 1640265 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of sphingolipid biosynthesis by fumonisins. Implications for diseases associated with Fusarium moniliforme. Wang E; Norred WP; Bacon CW; Riley RT; Merrill AH J Biol Chem; 1991 Aug; 266(22):14486-90. PubMed ID: 1860857 [TBL] [Abstract][Full Text] [Related]
19. Evidence for disruption of sphingolipid metabolism as a contributing factor in the toxicity and carcinogenicity of fumonisins. Riley RT; Wang E; Schroeder JJ; Smith ER; Plattner RD; Abbas H; Yoo HS; Merrill AH Nat Toxins; 1996; 4(1):3-15. PubMed ID: 8680751 [TBL] [Abstract][Full Text] [Related]